Abuse of anabolic‐androgenic steroids and bodybuilding acne: an underestimated health problem
暂无分享,去创建一个
[1] W. Schänzer,et al. Doping im Sport , 2007, Medizinische Klinik.
[2] I. Riezzo,et al. Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders , 2006, International Journal of Legal Medicine.
[3] E. J. Parry,et al. Acne induced by ‘Sus’ and ‘Deca’ , 2006, Clinical and experimental dermatology.
[4] H. Druid,et al. Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. , 2006, Drug and alcohol dependence.
[5] K. Dietz,et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. , 2006, Drug and alcohol dependence.
[6] Takashi Sato,et al. Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. , 2005, The Journal of investigative dermatology.
[7] C. Zouboulis. Sebaceous glands and the prostaglandin pathway--key stones of an exciting mosaic. , 2005, The Journal of investigative dermatology.
[8] K. Johns,et al. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. , 2005, The Cochrane database of systematic reviews.
[9] M. Link,et al. Cardiovascular toxicities of performance-enhancing substances in sports. , 2005, Mayo Clinic proceedings.
[10] Paul J Perry,et al. Anabolic Steroid Use in Weightlifters and Bodybuilders: An Internet Survey of Drug Utilization , 2005, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[11] G. Colditz,et al. Exposure to the Mass Media, Body Shape Concerns, and Use of Supplements to Improve Weight and Shape Among Male and Female Adolescents , 2005, Pediatrics.
[12] R. C. Hall,et al. Psychiatric complications of anabolic steroid abuse. , 2005, Psychosomatics.
[13] J. H. Hoffman,et al. Adolescent Anabolic Steroid Use, Gender, Physical Activity, and Other Problem Behaviors , 2005, Substance use & misuse.
[14] A. Boschnakow,et al. Zileuton, an Oral 5-Lipoxygenase Inhibitor, Directly Reduces Sebum Production , 2004, Dermatology.
[15] C. Zouboulis. Acne and sebaceous gland function. , 2004, Clinics in dermatology.
[16] A. Rane,et al. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology , 2003, European Journal of Clinical Pharmacology.
[17] H. Pope,et al. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. , 2003, Drug and alcohol dependence.
[18] H. Gollnick,et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. , 2003, Journal of the American Academy of Dermatology.
[19] W. Cunliffe,et al. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. , 2003, Archives of dermatology.
[20] P. Elsner,et al. Sport als Risikofaktor und therapeutisches Prinzip in der Dermatologie , 2002, Der Hautarzt.
[21] B. Fridlund,et al. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. , 2001, European journal of public health.
[22] G. Kanayama,et al. Over-the-Counter Drug Use in Gymnasiums: An Underrecognized Substance Abuse Problem? , 2001, Psychotherapy and Psychosomatics.
[23] P. Sanz,et al. Cryofibrinogenaemia with a good response to stanozolol , 2000, Clinical and experimental dermatology.
[24] R. Day,et al. Anabolic‐androgenic steroids: medical assessment of present, past and potential users , 2000, The Medical journal of Australia.
[25] R. Rosenfield,et al. Role of hormones in pilosebaceous unit development. , 2000, Endocrine reviews.
[26] H. Pope,et al. Anabolic-androgenic steroids as a gateway to opioid dependence. , 2000, The New England journal of medicine.
[27] D. Mackinnon,et al. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors. , 2000, Archives of pediatrics & adolescent medicine.
[28] D. Orgill,et al. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. , 2000, Journal of critical care.
[29] H. Sachs,et al. Testing for anabolic steroids in hair from two bodybuilders. , 1999, Forensic science international.
[30] A. Kentsis,et al. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. , 1999, The Journal of investigative dermatology.
[31] M. Van Loan,et al. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[32] A. Roberts,et al. Stimulation of collagen synthesis by the anabolic steroid stanozolol. , 1998, The Journal of investigative dermatology.
[33] G. Pierard. L'image du mois : Acne gymnasium : une acné fulminante dopée , 1998 .
[34] B. Maycock,et al. Current perspectives on anabolic steroids. , 1998, Drug and alcohol review.
[35] B. Towler,et al. General practitioners' views and knowledge about anabolic steroid use--survey of GPs in a high prevalence area. , 1997, Drug and alcohol review.
[36] G. Stimson,et al. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. , 1997, International journal of sports medicine.
[37] David Handelsman,et al. Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. , 1997, International journal of andrology.
[38] D. Mackinnon,et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. , 1996, JAMA.
[39] W. Wahli,et al. The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.
[40] Pirkko Korkia,et al. Use of anabolic steroids has been reported by 9% of men attending gymnasiums , 1996, BMJ.
[41] J. Gold,et al. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection , 1996, AIDS.
[42] J. Lear,et al. Anabolic steroids and psoriasis exacerbation , 1996, The British journal of dermatology.
[43] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[44] T. Helfman,et al. Stanozolol as a novel therapeutic agent in dermatology. , 1995, Journal of the American Academy of Dermatology.
[45] A. Lucky,et al. Hormonal correlates of acne and hirsutism. , 1995, The American journal of medicine.
[46] M. Debackere,et al. The Abuse of Doping Agents in Competing Body Builders in Flanders (1988-1993) , 1995, International journal of sports medicine.
[47] S. Liao,et al. Androgen receptor expression in the preputial gland and its sebocytes. , 1994, The Journal of investigative dermatology.
[48] P. Hull,et al. Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). , 1994, Journal of the American Academy of Dermatology.
[49] R. Durant,et al. Use of multiple drugs among adolescents who use anabolic steroids. , 1993, The New England journal of medicine.
[50] N. Penneys,et al. Immunohistochemical distribution of aromatase and 3B‐hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland , 1992, Journal of cutaneous pathology.
[51] M. J. Scott,et al. Effects of anabolic-androgenic steroids on the pilosebaceous unit. , 1992, Cutis.
[52] V. Rickert,et al. Adolescent body image and attitudes to anabolic steroid use. , 1992, American journal of diseases of children.
[53] O. Trygstad,et al. Acne in pubertal boys undergoing treatment with androgens. , 1992, Acta dermato-venereologica.
[54] L. Rossi Bernardi,et al. Evaluation of prevalence of "doping" among Italian athletes , 1990, The Lancet.
[55] M. Johnson,et al. Anabolic steroid use in adolescent athletes. , 1990, Pediatric clinics of North America.
[56] W. Yates,et al. Illicit anabolic steroid use in athletes , 1990, The American journal of sports medicine.
[57] M. Landthaler,et al. [Acne conglobata-like exacerbation of acne vulgaris following administration of anabolic steroids and vitamin B complex-containing preparations]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[58] E. Nieschlag,et al. Anabolic steroids and semen parameters in bodybuilders. , 1989, Fertility and sterility.
[59] K. Friedl,et al. Anabolic Steroid Use: Indications of Habituation among Adolescents , 1989, Journal of drug education.
[60] V. Rickert,et al. Anabolic steroid use by male adolescents. , 1989, Pediatrics.
[61] G. Heydenreich. Testosterone and anabolic steroids and acne fulminans. , 1989, Archives of dermatology.
[62] K. Friedl,et al. Estimated prevalence of anabolic steroid use among male high school seniors. , 1988, JAMA.
[63] D. Katz,et al. Anabolic-Androgenic Steroid Use Among 1,010 College Men. , 1988, The Physician and sportsmedicine.
[64] R. Happle,et al. Acne of the fulminans type following testosterone therapy in three excessively tall boys. , 1988, Archives of dermatology.
[65] Y. Collan,et al. Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. , 1987, The American Journal of dermatopathology.
[66] W. Cunliffe,et al. Is increased 5 alpha-reductase activity a primary phenomenon in androgen-dependent skin disorders? , 1987, The Journal of investigative dermatology.
[67] M. Alen,et al. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. , 1987, Acta dermato-venereologica.
[68] J. V. Toohey,et al. Non-medical drug use behaviour at five United States universities: a 15-year study. , 1985, Bulletin on narcotics.
[69] J. Gustafsson,et al. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. , 1984, Endocrinology.
[70] W. Cunliffe,et al. The Relationship Between the In Vitro Activity of 3β-Hydroxysteroid Dehydrogenase Δ4–5-Isomerase in Human Sebaceous Glands and Their Secretory Activity In Vivo , 1983 .
[71] M. Tóth,et al. Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone , 1982 .
[72] G. Plewig,et al. Hamster ear model for sebaceous glands. , 1977, The Journal of investigative dermatology.
[73] G. Sansone,et al. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin--a possible pathogenic factor in acne. , 1971, The Journal of investigative dermatology.
[74] A. Lenzi,et al. Biochemical evidence supporting the Cortina criteria. , 2005 .
[75] A. Lenzi,et al. Androgenic-anabolic steroids abuse in males. , 2005, Journal of endocrinological investigation.
[76] Harm Kuipers,et al. Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.
[77] G. Plewig. Akne und Rosazea , 1994 .
[78] M. J. Scott,et al. Linear keloids resulting from abuse of anabolic androgenic steroid drugs. , 1994, Cutis.
[79] E. Wilson,et al. The androgen receptor: an overview. , 1994, Recent progress in hormone research.
[80] W. Bartsch. Anabolic steroids--action on cellular level. , 1993, Wiener medizinische Wochenschrift.
[81] R. Terney,et al. The use of anabolic steroids in high school students. , 1990, American journal of diseases of children.
[82] A. A. Hartmann,et al. Acne fulminans bei Klinefelter-Syndrom unter Testosteron. Eine Nebenwirkung der Antihochwuchstherapie , 1989 .
[83] M. Alen,et al. The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men. , 1988, Acta dermato-venereologica.
[84] D. MacDougall. Anabolic Steroids. , 1983, The Physician and sportsmedicine.